erlotinib hydrochloride has been researched along with Pulmonary Arterial Hypertension in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhoble, S; Patravale, V | 1 |
1 other study(ies) available for erlotinib hydrochloride and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach.
Topics: Angiogenesis Inhibitors; Animal Fins; Animals; Drug Design; Drug Liberation; Erlotinib Hydrochloride; Liposomes; Protein Kinase Inhibitors; Pulmonary Arterial Hypertension; Regeneration; Zebrafish | 2019 |